Why It Matters

Hospital for Special Surgery (HSS), the New York-based orthopedic institution, has registered to lobby the federal government for the first time, according to a new disclosure filed June 5, 2026. The in-house registration signals a direct push into federal policy on health care, Medicare and Medicaid, and medical research. Rather than hiring an outside firm, HSS is deploying its own institutional leadership to make its case on Capitol Hill.

The disclosure identifies three broad issue areas: health care reform, Medicare and Medicaid policy, and medical and disease research and clinical labs.

The Big Picture

HSS is entering the lobbying arena at a moment when Congress is actively debating policies that could directly affect how surgical hospitals and research institutions are paid and regulated. The legislative environment around Medicare reimbursement for outpatient surgery, clinical laboratory fee schedules, and access to Medicare claims data for research has been particularly active in the past year. Proposed cuts to Medicaid and Medicare have also dominated congressional debate as part of broader budget negotiations.

Several pieces of legislation relevant to HSS's stated lobbying areas have moved through Congress in the past year.

On Medicare payment for surgical facilities, Rep. Beth Van Duyne (R-TX-24) and Rep. John B. Larson (D-CT-1) introduced the bipartisan Outpatient Surgery Access Act of 2026 in March. The bill would align annual Medicare payment updates for ambulatory surgical centers with hospital outpatient departments and eliminate ASC-specific budget neutrality adjustments.

On clinical lab reimbursements, the RESULTS Act was introduced in September 2025 by a bipartisan group including Rep. Gus Bilirakis (R-FL-12), Rep. Scott Peters (D-CA-50), and Rep. Richard Hudson (R-NC-9). The bill would freeze Medicare clinical lab payment rates at 2025 levels, cap future cuts at 5 percent annually, and use an independent commercial claims database to set rates.

On medical research, Rep. Kim Schrier (D-WA-8) introduced the Access to Claims Data Act in July 2025 alongside John Joyce (R-PA), marking another bipartisan legislative effort. The bill would require the Centers for Medicare and Medicaid Services to allow clinician-led clinical data registries access to Medicare claims data for research and quality measurement. The American Association of Orthopaedic Surgeons endorsed the bill, citing its five musculoskeletal clinical data registries as direct beneficiaries.

Rep. Chrissy Houlahan (D-PA-6) also raised concerns in October 2025 about Medicare and Medicaid underpayments to hospitals, stating she would "continue to oppose cuts to Medicare and Medicaid reimbursements."

The Bottom Line

HSS's new in-house lobbying registration puts the institution directly in a federal policy debate that has real consequences for hospital reimbursement and research funding. The timing aligns with active congressional attention to Medicare payment reform across surgical centers, clinical labs, and research data access. Whether the registration translates into meaningful engagement will depend on what specific priorities HSS pursues in the quarters ahead.

Access the Legis1 platform for comprehensive political news, data, and insights.